4.8 • 1K Ratings
🗓️ 25 March 2023
⏱️ 53 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | Welcome to Everyday Wellness Podcast. I'm your host, Nurse Practitioner Cynthia Thurlow. |
0:07.0 | This podcast is designed to educate, empower, and inspire you to achieve your health and wellness goals. |
0:14.0 | My goal and intent is to provide you with the best content and conversations from leaders in the |
0:19.2 | health and wellness industry each week and impact over a million lives. |
0:23.4 | Today I had the honor of reconnecting with Dr. Tracy Gappin. He is a board certified urologist and |
0:35.4 | men's health expert and with the current state of metabolic health in the |
0:40.7 | United States and actually in most Westernized countries. There's been great interest in a GLP1 agonist, aka semi-glutide Ozempeck. And I wanted to bring a clinician on that is actively utilizing this medication. |
0:57.1 | We spoke about what this drug class represents. |
1:00.3 | These are synthetic peptides. We spoke at great length about semi-glutide in particular as well as |
1:07.3 | Ozempeck and Weagovi as well as oral rivalous. We discussed current research, side effects who should not take these medications and spent quite a bit of time talking about mechanisms of action specific to the pancreas and beta cells, reductions in gastric emptying and satiety being upregulated, as well as specific changes in the brain with regard to lepton and how these drugs work and manifest. We spoke about weight loss resistance. I answered many listeners questions. Thank you for submitting those. And you know, from my perspective, it really comes back to basics. If we are going to be prescribing these medications and let me be clear I'm not currently doing so, but if we are going to be prescribing these medications, we owe our patients the opportunity to really understand how lifestyle impacts |
1:58.4 | weight loss resistance as well as metabolic health and I love that Dr. Tracy spent quite a bit of time talking about |
2:04.8 | specific ways that he works with his patients even prior to prescribing medications |
2:10.4 | but how important he has felt that this drug has been to his given patient population and I think I went into this conversation with a very open mind and I hope you will |
2:25.0 | to have you back. |
2:27.0 | Thank you for carving time out of your busy schedule to talk about a topic that is getting a lot of attention, |
2:33.2 | Ozemphic, semi-glutide, Weagovi, all these drugs. |
2:38.8 | Tell me from your perspective, I mean, obviously you've been a urologist for a long time. |
2:44.4 | When did they kind of fall onto your radar in terms of your given patient population and you work in full disclosure |
2:49.8 | you work with men but still when did you start utilizing these drugs and what has been kind of the |
2:57.0 | progression of using them or using them with greater frequency now? I'm sure people are probably coming directly to you and |
3:03.5 | asking for them. Yeah, yeah, absolutely. And first of all, thanks so much for having me |
3:07.4 | on your show again today. I love you. I love all your content. You're amazing human being, so I'm glad to be with you tonight, first of all. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Cynthia Thurlow, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Cynthia Thurlow and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.